Your browser doesn't support javascript.
loading
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.
Shah, Mithun Vinod; Tran, Elizabeth Ngoc Hoa; Shah, Syed; Chhetri, Rakchha; Baranwal, Anmol; Ladon, Dariusz; Shultz, Carl; Al-Kali, Aref; Brown, Anna L; Chen, Dong; Scott, Hamish S; Greipp, Patricia; Thomas, Daniel; Alkhateeb, Hassan B; Singhal, Deepak; Gangat, Naseema; Kumar, Sharad; Patnaik, Mrinal M; Hahn, Christopher N; Kok, Chung Hoow; Tefferi, Ayalew; Hiwase, Devendra K.
Afiliação
  • Shah MV; Division of Hematology, Mayo Clinic, Rochester, MN, USA. shah.mithun@mayo.edu.
  • Tran ENH; Precision Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
  • Shah S; University of Adelaide, Adelaide, SA, Australia.
  • Chhetri R; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Baranwal A; Precision Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
  • Ladon D; University of Adelaide, Adelaide, SA, Australia.
  • Shultz C; Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, SA, Australia.
  • Al-Kali A; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Brown AL; Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
  • Chen D; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Scott HS; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Greipp P; University of Adelaide, Adelaide, SA, Australia.
  • Thomas D; Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
  • Alkhateeb HB; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.
  • Singhal D; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Gangat N; University of Adelaide, Adelaide, SA, Australia.
  • Kumar S; Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
  • Patnaik MM; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.
  • Hahn CN; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Kok CH; Precision Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
  • Tefferi A; University of Adelaide, Adelaide, SA, Australia.
  • Hiwase DK; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Blood Cancer J ; 13(1): 51, 2023 04 11.
Article em En | MEDLINE | ID: mdl-37041128
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Proteína Supressora de Tumor p53 / Frequência do Gene Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Proteína Supressora de Tumor p53 / Frequência do Gene Idioma: En Ano de publicação: 2023 Tipo de documento: Article